In addition, we tested the mRNA level changes of PRMT5 and FXR1 in The Cancer Genome Atlas (TCGA) HNSCC and lung adenocarcinoma data sets. This evidence concerns the gene PRMT5 and head and neck squamous cell carcinoma.